Logo image
Extracellular Adenosine 5'-Triphosphate in Obstructive Airway Diseases
Journal article   Open access   Peer reviewed

Extracellular Adenosine 5'-Triphosphate in Obstructive Airway Diseases

Amir Pelleg, Edward S. Schulman and Peter J. Barnes
Chest, v 150(4), pp 908-915
Oct 2016
PMID: 27568579
url
https://doi.org/10.1016/j.chest.2016.06.045View
Published, Version of Record (VoR)Maybe Open Access (Publisher Bronze) Open

Abstract

ATP COPD cough inflammation P2 receptors
In recent years, numerous studies have generated data supporting the hypothesis that extracellular adenosine 5′-triphosphate (ATP) plays a major role in obstructive airway diseases. Studies in animal models and human subjects have shown that increased amounts of extracellular ATP are found in the lungs of patients with COPD and asthma and that ATP has effects on multiple cell types in the lungs, resulting in increased inflammation, induction of bronchoconstriction, and cough. These effects of ATP are mediated by cell surface P2 purinergic receptors and involve other endogenous inflammatory agents. Recent clinical trials reported promising treatment with P2X3R antagonists for the alleviation of chronic cough. The purpose of this review was to describe these studies and outline some of the remaining questions, as well as the potential clinical implications, associated with the pharmacologic manipulation of ATP signaling in the lungs.

Metrics

12 Record Views
37 citations in Scopus

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Collaboration types
Domestic collaboration
International collaboration
Web of Science research areas
Critical Care Medicine
Respiratory System
Logo image